S&P 500   4,221.02
DOW   33,061.57
QQQ   352.01
Is This The Collapse of Icahn Enterprises ?
“Amazon Loophole” could hand you $28,544 in “royalty” payouts (Ad)
20 Best Healthcare Dividend Stocks to Invest in
Money stored in Venmo and other payment apps could be vulnerable, financial watchdog warns
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Nordstrom's Earnings Beat, A Rally In The Making
Elliott Management Says Goodyear Tire Worth At Least $21 a Share
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
What Does the Airbnb Guidance Drop Say About Travel Demand?
What is the Penalty for Excess Contributions to an IRA?
S&P 500   4,221.02
DOW   33,061.57
QQQ   352.01
Is This The Collapse of Icahn Enterprises ?
“Amazon Loophole” could hand you $28,544 in “royalty” payouts (Ad)
20 Best Healthcare Dividend Stocks to Invest in
Money stored in Venmo and other payment apps could be vulnerable, financial watchdog warns
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Nordstrom's Earnings Beat, A Rally In The Making
Elliott Management Says Goodyear Tire Worth At Least $21 a Share
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
What Does the Airbnb Guidance Drop Say About Travel Demand?
What is the Penalty for Excess Contributions to an IRA?
S&P 500   4,221.02
DOW   33,061.57
QQQ   352.01
Is This The Collapse of Icahn Enterprises ?
“Amazon Loophole” could hand you $28,544 in “royalty” payouts (Ad)
20 Best Healthcare Dividend Stocks to Invest in
Money stored in Venmo and other payment apps could be vulnerable, financial watchdog warns
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Nordstrom's Earnings Beat, A Rally In The Making
Elliott Management Says Goodyear Tire Worth At Least $21 a Share
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
What Does the Airbnb Guidance Drop Say About Travel Demand?
What is the Penalty for Excess Contributions to an IRA?
S&P 500   4,221.02
DOW   33,061.57
QQQ   352.01
Is This The Collapse of Icahn Enterprises ?
“Amazon Loophole” could hand you $28,544 in “royalty” payouts (Ad)
20 Best Healthcare Dividend Stocks to Invest in
Money stored in Venmo and other payment apps could be vulnerable, financial watchdog warns
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Nordstrom's Earnings Beat, A Rally In The Making
Elliott Management Says Goodyear Tire Worth At Least $21 a Share
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
What Does the Airbnb Guidance Drop Say About Travel Demand?
What is the Penalty for Excess Contributions to an IRA?
NASDAQ:SHCR

Sharecare (SHCR) Price Target & Analyst Ratings

$1.59
+0.10 (+6.71%)
(As of 06/1/2023 ET)
Compare
Today's Range
$1.47
▼
$1.61
50-Day Range
$1.36
▼
$2.23
52-Week Range
$1.31
▼
$3.20
Volume
6.05 million shs
Average Volume
1.26 million shs
Market Capitalization
$568.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.02
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media

Sharecare Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 5 Analyst Ratings

Consensus Analyst Price Target

$3.02
89.94% Upside
High Prediction$5.00
Average Prediction$3.02
Low Prediction$2.00
TypeCurrent
6/2/22 to 6/2/23		1 Month Ago
5/3/22 to 5/3/23		3 Months Ago
3/4/22 to 3/4/23		1 Year Ago
6/2/21 to 6/2/22
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
1 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$3.02$3.02$3.12$6.67
Predicted Upside89.94% Upside68.53% Upside71.05% Upside162.67% Upside
Get Sharecare Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for SHCR and its competitors with MarketBeat's FREE daily newsletter.


SHCR Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SHCR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Sharecare Stock vs. The Competition

TypeSharecareMedical CompaniesS&P 500
Consensus Rating Score
2.60
2.66
2.48
Consensus RatingModerate BuyBuyHold
Predicted Upside89.94% Upside1,273.91% Upside203.34% Upside
News Sentiment RatingPositive News
Neutral News
Positive News

Historical Target Prices and Ratings

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/30/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetEqual Weight$2.50 ➝ $2.00+36.99%
11/11/2022Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Richard Close
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower TargetBuy ➝ Buy$4.00 ➝ $3.00+72.41%
10/5/2022BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating		David Larsen
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower TargetBuy$8.00 ➝ $5.00+145.10%
9/21/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetNeutral$1.50 ➝ $2.10+6.06%
(Data available from 6/2/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












SHCR Price Target - Frequently Asked Questions

What is Sharecare's consensus rating and price target?

According to the issued ratings of 5 analysts in the last year, the consensus rating for Sharecare stock is Moderate Buy based on the current 2 hold ratings and 3 buy ratings for SHCR. The average twelve-month price prediction for Sharecare is $3.02 with a high price target of $5.00 and a low price target of $2.00. Learn more on SHCR's analyst rating history.

Do Wall Street analysts like Sharecare more than its competitors?

Analysts like Sharecare less than other Medical companies. The consensus rating for Sharecare is Moderate Buy while the average consensus rating for medical companies is Buy. Learn more on how SHCR compares to other companies.

Does Sharecare's stock price have much upside?

According to analysts, Sharecare's stock has a predicted upside of 68.53% based on their 12-month price targets.

What analysts cover Sharecare?

Sharecare has been rated by Morgan Stanley in the past 90 days.


Stock Ratings Reports and Tools

Related Companies:
Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
This page (NASDAQ:SHCR) was last updated on 6/2/2023 by MarketBeat.com Staff

My Account -